ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study.

W. Arns,1 J. Cruzado,1 H. Holdaas,1 P. Lopez,2 P. Bernhardt,2 G. Bader,2 F. Claas,1 M. van der Giet,1 J. de Fijter.1

1ELEVATE Study Group, Köln, Germany
2Novartis Pharma AG, Basel, Switzerland

Meeting: 2017 American Transplant Congress

Abstract number: D67

Keywords: Efficacy, HLA matching, Kidney transplantation, Renal function

Session Information

Session Name: Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Purpose: Human leukocyte antigen (HLA)-DQ mismatches are often associated with acute rejection, independent of mismatches at other loci. Previous analysis from the ELEVATE (NCT01114529) study showed the effect of HLA-DR mismatch on renal allograft outcomes in kidney transplant recipients (KTxRs). Here, we present the effect of split and broad HLA-DQ mismatch on efficacy and safety in KTxRs receiving everolimus (EVR) vs standard calcineurin inhibitor (CNI).

Methods: ELEVATE was a 24-month (M), multicenter, open-label study, in which de novo KTxRs were randomized at 10-14 weeks post-kidney transplant (KTx) to receive EVR (n=360; C0: 6-10 ng/mL) or continue CNI regimen (n=357; tacrolimus [TAC] C0: 5-10 ng/mL; cyclosporine [CsA] C0: 100-250 ng/mL). Donor-recipient HLA-DQ mismatches were determined for split or broad categories. Composite efficacy failure (CEF; treated biopsy-proven acute rejection, graft loss, or death), acute rejection (AR), and antibody-mediated rejection (AMR) at M24 post-Tx were assessed. Renal function was assessed as estimated glomerular filtration rate (eGFR, MDRD4).

Results: Overall, 64 and 79 patients had split mismatch and 27 and 23 patients had broad mismatch in the EVR and CNI arm, respectively. At M24, CEF, AR, and AMR events were numerically higher in EVR vs CNI arm for split mismatch. However, for broad mismatch, all efficacy events were comparable between both the arms. eGFR was numerically higher in EVR vs CNI arm for both split and broad mismatch groups [Table]. Moreover, eGFR was significantly higher in EVR vs CsA arm for split mismatch group (P<0.05). Adverse events (AEs)/serious AEs were comparable between both arms. AEs/infections leading to discontinuation were higher in EVR vs CNI arm (split mismatch: 33.3% vs 13.8%; broad mismatch: 25.9% vs 13.0%).

Conclusion: EVR appears to offer better renal function despite higher efficacy failure and safety events vs CNI irrespective of the presence of split or broad mismatch at HLA-DQ loci. Assessment with larger samples is warranted to confirm these findings.

CITATION INFORMATION: Arns W, Cruzado J, Holdaas H, Lopez P, Bernhardt P, Bader G, Claas F, van der Giet M, de Fijter J. Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Arns W, Cruzado J, Holdaas H, Lopez P, Bernhardt P, Bader G, Claas F, Giet Mvander, Fijter Jde. Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/effect-of-hla-dq-mismatch-on-efficacy-outcomes-and-renal-function-in-kidney-transplant-recipients-subanalysis-from-the-elevate-study/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences